The Hospital Universitario San Ignacio is a 4th level university hospital in Bogotá, Colombia. It is located within campus of the Pontificia Universidad Javeriana and is home to this school's faculties of Medicine, Nursing and Dentistry.

There are 300 beds in Hospital Universitario San Ignacio.

During the past decade, Hospital Universitario San Ignacio conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 7 clinical trials were completed, i.e. on average, 35% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 2 clinical trials were completed. i.e. 18.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Universitario San Ignacio" #1 sponsor was "Hoffmann-La Roche" with 5 trials, followed by "Javeriana University" with 5 trials sponsored, "Biogen" with 2 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Hospital Universitario San Ignacio" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitario San Ignacio" #1 collaborator was "Hospital Universitario San Ignacio" with 8 trials as a collaborator, "Pontificia Universidad Javeriana" with 5 trials as a collaborator, "Fundación Cardioinfantil Instituto de Cardiología" with 2 trials as a collaborator, "Asociacion Colombiana de Infectologia, ACIN. Infectious Diseases Society of Colombia" with 1 trials as a collaborator and "Basic Health International" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Universitario San Ignacio" are "Lupus Nephritis" (3 trials), "Cardiovascular Disease" (2 trials), "Critically Ill" (2 trials), "Jaundice, Neonatal" (2 trials) and "Muscular Atrophy, Spinal" (2 trials). Many other conditions were trialed in "Hospital Universitario San Ignacio" in a lesser frequency.

Most popular intervention types in "Hospital Universitario San Ignacio" are "Drug" (22 trials), "Device" (6 trials), "Dietary Supplement" (3 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Prednisone" (3 trials), "Methylprednisolone" (2 trials), "Nusinersen" (2 trials) and "Obinutuzumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Universitario San Ignacio" are 30 trials for "All" genders, 3 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Universitario San Ignacio". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 18 completed trials in Hospital Universitario San Ignacio, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Universitario San Ignacio, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 5 trials that are defined as “Not Applicable".

Hospital Universitario San Ignacio has several departments that took part in Clinical trials: "Centro Javeriano de Oncología" - 3 trials